Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 54 entries
Sorted by: Best Match Show Resources per page
Seawater drowning-associated pneumonia: a 10-year descriptive cohort in intensive care unit.

Annals of intensive care

Robert A, Danin PÉ, Quintard H, Degand N, Martis N, Doyen D, Pulcini C, Ruimy R, Ichai C, Bernardin G, Dellamonica J.
PMID: 28447330
Ann Intensive Care. 2017 Dec;7(1):45. doi: 10.1186/s13613-017-0267-4. Epub 2017 Apr 26.

BACKGROUND: Pneumonia is one of the major complications of drowning, but the optimal empirical antibiotic treatment is not clearly defined. Multidrug-resistant (MDR) bacteria and fungi have been identified in a recent series of freshwater drowning-associated pneumonia. However, microbial data...

Cite
Robert A, Danin PÉ, Quintard H, et al. Seawater drowning-associated pneumonia: a 10-year descriptive cohort in intensive care unit. Ann Intensive Care. 2017;7(1):45doi: 10.1186/s13613-017-0267-4.
Robert, A., Danin, P. �. �., Quintard, H., Degand, N., Martis, N., Doyen, D., Pulcini, C., Ruimy, R., Ichai, C., Bernardin, G., & Dellamonica, J. (2017). Seawater drowning-associated pneumonia: a 10-year descriptive cohort in intensive care unit. Annals of intensive care, 7(1), 45. https://doi.org/10.1186/s13613-017-0267-4
Robert, Alexandre, et al. "Seawater drowning-associated pneumonia: a 10-year descriptive cohort in intensive care unit." Annals of intensive care vol. 7,1 (2017): 45. doi: https://doi.org/10.1186/s13613-017-0267-4
Robert A, Danin PÉ, Quintard H, Degand N, Martis N, Doyen D, Pulcini C, Ruimy R, Ichai C, Bernardin G, Dellamonica J. Seawater drowning-associated pneumonia: a 10-year descriptive cohort in intensive care unit. Ann Intensive Care. 2017 Dec;7(1):45. doi: 10.1186/s13613-017-0267-4. Epub 2017 Apr 26. PMID: 28447330; PMCID: PMC5406314.
Copy Download .nbib Format: NLM
Thioether-triphenolate bimetallic iron(III) complexes as robust and highly efficient catalysts for cycloaddition of carbon dioxide to epoxides.

Faraday discussions

Buonerba A, Della Monica F, De Nisi A, Luciano E, Milione S, Grassi A, Capacchione C, Rieger B.
PMID: 26402776
Faraday Discuss. 2015;183:83-95. doi: 10.1039/c5fd00070j.

The selective and effective synthesis of organic carbonates under mild conditions, starting from carbon dioxide and oxiranes, catalyzed by metal complexes is currently a focus of interest for both industrial and academic researchers. We recently developed a novel thioether-triphenolate...

Cite
Buonerba A, Della Monica F, De Nisi A, et al. Thioether-triphenolate bimetallic iron(III) complexes as robust and highly efficient catalysts for cycloaddition of carbon dioxide to epoxides. Faraday Discuss. 2015;183:83-95doi: 10.1039/c5fd00070j.
Buonerba, A., Della Monica, F., De Nisi, A., Luciano, E., Milione, S., Grassi, A., Capacchione, C., & Rieger, B. (2015). Thioether-triphenolate bimetallic iron(III) complexes as robust and highly efficient catalysts for cycloaddition of carbon dioxide to epoxides. Faraday discussions, 18383-95. https://doi.org/10.1039/c5fd00070j
Buonerba, Antonio, et al. "Thioether-triphenolate bimetallic iron(III) complexes as robust and highly efficient catalysts for cycloaddition of carbon dioxide to epoxides." Faraday discussions vol. 183 (2015): 83-95. doi: https://doi.org/10.1039/c5fd00070j
Buonerba A, Della Monica F, De Nisi A, Luciano E, Milione S, Grassi A, Capacchione C, Rieger B. Thioether-triphenolate bimetallic iron(III) complexes as robust and highly efficient catalysts for cycloaddition of carbon dioxide to epoxides. Faraday Discuss. 2015;183:83-95. doi: 10.1039/c5fd00070j. PMID: 26402776.
Copy Download .nbib Format: NLM
Sustaining the spindle assembly checkpoint to improve cancer therapy.

Molecular & cellular oncology

Visconti R, Della Monica R, Grieco D.
PMID: 27308561
Mol Cell Oncol. 2015 Jun 26;3(1):e1046583. doi: 10.1080/23723556.2015.1046583. eCollection 2016 Jan.

To prevent chromosome segregation errors, the spindle assembly checkpoint (SAC) delays mitosis exit until proper spindle assembly. We found that the FCP1 phosphatase and its downstream target WEE1 kinase oppose the SAC, promoting mitosis exit despite malformed spindles. We...

Cite
Visconti R, Della Monica R, Grieco D. Sustaining the spindle assembly checkpoint to improve cancer therapy. Mol Cell Oncol. 2015;3(1):e1046583doi: 10.1080/23723556.2015.1046583.
Visconti, R., Della Monica, R., & Grieco, D. (2016). Sustaining the spindle assembly checkpoint to improve cancer therapy. Molecular & cellular oncology, 3(1), e1046583. https://doi.org/10.1080/23723556.2015.1046583
Visconti, Roberta, et al. "Sustaining the spindle assembly checkpoint to improve cancer therapy." Molecular & cellular oncology vol. 3,1 (2016): e1046583. doi: https://doi.org/10.1080/23723556.2015.1046583
Visconti R, Della Monica R, Grieco D. Sustaining the spindle assembly checkpoint to improve cancer therapy. Mol Cell Oncol. 2015 Jun 26;3(1):e1046583. doi: 10.1080/23723556.2015.1046583. eCollection 2016 Jan. PMID: 27308561; PMCID: PMC4845201.
Copy Download .nbib Format: NLM
Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Bailly L, Fabre R, Courjon J, Carles M, Dellamonica J, Pradier C.
PMID: 34537362
Clin Microbiol Infect. 2022 Jan;28(1):114-123. doi: 10.1016/j.cmi.2021.09.010. Epub 2021 Sep 16.

OBJECTIVES: Initial studies of individuals with coronavirus disease 2019 (COVID-19) revealed that obesity, diabetes and hypertension were associated with severe outcomes. Subsequently, some authors showed that the risk could vary according to age, gender, co-morbidities and medical history. In...

Cite
Bailly L, Fabre R, Courjon J, et al. Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study. Clin Microbiol Infect. 2021;28(1):114-123doi: 10.1016/j.cmi.2021.09.010.
Bailly, L., Fabre, R., Courjon, J., Carles, M., Dellamonica, J., & Pradier, C. (2022). Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 28(1), 114-123. https://doi.org/10.1016/j.cmi.2021.09.010
Bailly, Laurent, et al. "Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 28,1 (2022): 114-123. doi: https://doi.org/10.1016/j.cmi.2021.09.010
Bailly L, Fabre R, Courjon J, Carles M, Dellamonica J, Pradier C. Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study. Clin Microbiol Infect. 2022 Jan;28(1):114-123. doi: 10.1016/j.cmi.2021.09.010. Epub 2021 Sep 16. PMID: 34537362; PMCID: PMC8444420.
Copy Download .nbib Format: NLM
Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy.

Annals of intensive care

Claustre J, Larcher R, Jouve T, Truche AS, Nseir S, Cadiet J, Zerbib Y, Lautrette A, Constantin JM, Charles PE, Daubin C, Coudroy R, Dellamonica J, Argaud L, Phelouzat P, Contou D, Pocquet J, Voiriot G, Navellou JC, Lavagne P, Durand M, Cornet M, Schwebel C, Terzi N.
PMID: 32514787
Ann Intensive Care. 2020 Jun 08;10(1):74. doi: 10.1186/s13613-020-00673-9.

BACKGROUND: Mucormycosis is an invasive fungal infection, with an increasing incidence especially in patients with hematological malignancies. Its prognosis is poor because of its high invasive power and its intrinsic low susceptibility to antifungal agents. We aimed to describe...

Cite
Claustre J, Larcher R, Jouve T, et al. Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy. Ann Intensive Care. 2020;10(1):74doi: 10.1186/s13613-020-00673-9.
Claustre, J., Larcher, R., Jouve, T., Truche, A. S., Nseir, S., Cadiet, J., Zerbib, Y., Lautrette, A., Constantin, J. M., Charles, P. E., Daubin, C., Coudroy, R., Dellamonica, J., Argaud, L., Phelouzat, P., Contou, D., Pocquet, J., Voiriot, G., Navellou, J. C., Lavagne, P., Durand, M., Cornet, M., Schwebel, C., & Terzi, N. (2020). Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy. Annals of intensive care, 10(1), 74. https://doi.org/10.1186/s13613-020-00673-9
Claustre, Johanna, et al. "Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy." Annals of intensive care vol. 10,1 (2020): 74. doi: https://doi.org/10.1186/s13613-020-00673-9
Claustre J, Larcher R, Jouve T, Truche AS, Nseir S, Cadiet J, Zerbib Y, Lautrette A, Constantin JM, Charles PE, Daubin C, Coudroy R, Dellamonica J, Argaud L, Phelouzat P, Contou D, Pocquet J, Voiriot G, Navellou JC, Lavagne P, Durand M, Cornet M, Schwebel C, Terzi N. Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy. Ann Intensive Care. 2020 Jun 08;10(1):74. doi: 10.1186/s13613-020-00673-9. PMID: 32514787; PMCID: PMC7280386.
Copy Download .nbib Format: NLM
Evaluation of MGMT gene methylation in neuroendocrine neoplasms.

Oncology research

Della Monica R, Cuomo M, Visconti R, di Mauro A, Buonaiuto M, Costabile D, De Riso G, Di Risi T, Guadagno E, Tafuto R, Lamia S, Ottaiano A, Cappabianca P, Del Basso de Caro ML, Tatangelo F, Hench J, Frank S, Tafuto S, Chiariotti L.
PMID: 34016221
Oncol Res. 2021 May 20; doi: 10.3727/096504021X16214197880808. Epub 2021 May 20.

Unresectable neuroendocrine neoplasms (NENs) often poorly respond to standard therapeutic approaches. Alkylating agents, in particular temozolomide, commonly used to treat high-grade brain tumors including glioblastomas, have recently been tested in advanced or metastatic NENs, where they showed promising response...

Cite
Della Monica R, Cuomo M, Visconti R, et al. Evaluation of MGMT gene methylation in neuroendocrine neoplasms. Oncol Res. 2021;doi: 10.3727/096504021X16214197880808.
Della Monica, R., Cuomo, M., Visconti, R., di Mauro, A., Buonaiuto, M., Costabile, D., De Riso, G., Di Risi, T., Guadagno, E., Tafuto, R., Lamia, S., Ottaiano, A., Cappabianca, P., Del Basso de Caro, M. L., Tatangelo, F., Hench, J., Frank, S., Tafuto, S., & Chiariotti, L. (2021). Evaluation of MGMT gene methylation in neuroendocrine neoplasms. Oncology research, . https://doi.org/10.3727/096504021X16214197880808
Della Monica, Rosa, et al. "Evaluation of MGMT gene methylation in neuroendocrine neoplasms." Oncology research vol. (2021). doi: https://doi.org/10.3727/096504021X16214197880808
Della Monica R, Cuomo M, Visconti R, di Mauro A, Buonaiuto M, Costabile D, De Riso G, Di Risi T, Guadagno E, Tafuto R, Lamia S, Ottaiano A, Cappabianca P, Del Basso de Caro ML, Tatangelo F, Hench J, Frank S, Tafuto S, Chiariotti L. Evaluation of MGMT gene methylation in neuroendocrine neoplasms. Oncol Res. 2021 May 20; doi: 10.3727/096504021X16214197880808. Epub 2021 May 20. PMID: 34016221.
Copy Download .nbib Format: NLM
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial.

The Lancet. Respiratory medicine

Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E.
PMID: 34425070
Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.

BACKGROUND: Awake prone positioning has been reported to improve oxygenation for patients with COVID-19 in retrospective and observational studies, but whether it improves patient-centred outcomes is unknown. We aimed to evaluate the efficacy of awake prone positioning to prevent...

Cite
Ehrmann S, Li J, Ibarra-Estrada M, et al. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021;9(12):1387-1395doi: 10.1016/S2213-2600(21)00356-8.
Ehrmann, S., Li, J., Ibarra-Estrada, M., Perez, Y., Pavlov, I., McNicholas, B., Roca, O., Mirza, S., Vines, D., Garcia-Salcido, R., Aguirre-Avalos, G., Trump, M. W., Nay, M. A., Dellamonica, J., Nseir, S., Mogri, I., Cosgrave, D., Jayaraman, D., Masclans, J. R., Laffey, J. G., Tavernier, E. (2021). Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. The Lancet. Respiratory medicine, 9(12), 1387-1395. https://doi.org/10.1016/S2213-2600(21)00356-8
Ehrmann, Stephan, et al. "Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial." The Lancet. Respiratory medicine vol. 9,12 (2021): 1387-1395. doi: https://doi.org/10.1016/S2213-2600(21)00356-8
Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20. PMID: 34425070; PMCID: PMC8378833.
Copy Download .nbib Format: NLM
Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study.

Frontiers in medicine

Cremoni M, Ruetsch C, Zorzi K, Fernandez C, Boyer-Suavet S, Benzaken S, Demonchy E, Dellamonica J, Ichai C, Esnault V, Brglez V, Seitz-Polski B.
PMID: 33585509
Front Med (Lausanne). 2021 Jan 27;7:608804. doi: 10.3389/fmed.2020.608804. eCollection 2020.

Frontline health care workers (HCWs) have been particularly exposed to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) since the start of the pandemic but the clinical features and immune responses of those infected with SARS-CoV-2 have not been well...

Cite
Cremoni M, Ruetsch C, Zorzi K, et al. Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study. Front Med (Lausanne). 2021;7:608804doi: 10.3389/fmed.2020.608804.
Cremoni, M., Ruetsch, C., Zorzi, K., Fernandez, C., Boyer-Suavet, S., Benzaken, S., Demonchy, E., Dellamonica, J., Ichai, C., Esnault, V., Brglez, V., & Seitz-Polski, B. (2020). Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study. Frontiers in medicine, 7608804. https://doi.org/10.3389/fmed.2020.608804
Cremoni, Marion, et al. "Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study." Frontiers in medicine vol. 7 (2020): 608804. doi: https://doi.org/10.3389/fmed.2020.608804
Cremoni M, Ruetsch C, Zorzi K, Fernandez C, Boyer-Suavet S, Benzaken S, Demonchy E, Dellamonica J, Ichai C, Esnault V, Brglez V, Seitz-Polski B. Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study. Front Med (Lausanne). 2021 Jan 27;7:608804. doi: 10.3389/fmed.2020.608804. eCollection 2020. PMID: 33585509; PMCID: PMC7873459.
Copy Download .nbib Format: NLM
Noninvasive ventilation vs. high-flow nasal cannula oxygen for preoxygenation before intubation in patients with obesity: a post hoc analysis of a randomized controlled trial.

Annals of intensive care

Rodriguez M, Ragot S, Coudroy R, Quenot JP, Vignon P, Forel JM, Demoule A, Mira JP, Ricard JD, Nseir S, Colin G, Pons B, Danin PE, Devaquet J, Prat G, Merdji H, Petitpas F, Vivier E, Mekontso-Dessap A, Nay MA, Asfar P, Dellamonica J, Argaud L, Ehrmann S, Fartoukh M, Girault C, Robert R, Thille AW, Frat JP.
PMID: 34292408
Ann Intensive Care. 2021 Jul 22;11(1):114. doi: 10.1186/s13613-021-00892-8.

BACKGROUND: Critically ill patients with obesity may have an increased risk of difficult intubation and subsequent severe hypoxemia. We hypothesized that pre-oxygenation with noninvasive ventilation before intubation as compared with high-flow nasal cannula oxygen may decrease the risk of...

Cite
Rodriguez M, Ragot S, Coudroy R, et al. Noninvasive ventilation vs. high-flow nasal cannula oxygen for preoxygenation before intubation in patients with obesity: a post hoc analysis of a randomized controlled trial. Ann Intensive Care. 2021;11(1):114doi: 10.1186/s13613-021-00892-8.
Rodriguez, M., Ragot, S., Coudroy, R., Quenot, J. P., Vignon, P., Forel, J. M., Demoule, A., Mira, J. P., Ricard, J. D., Nseir, S., Colin, G., Pons, B., Danin, P. E., Devaquet, J., Prat, G., Merdji, H., Petitpas, F., Vivier, E., Mekontso-Dessap, A., Nay, M. A., Asfar, P., Dellamonica, J., Argaud, L., Ehrmann, S., Fartoukh, M., Girault, C., Robert, R., Thille, A. W., Frat, J. P. (2021). Noninvasive ventilation vs. high-flow nasal cannula oxygen for preoxygenation before intubation in patients with obesity: a post hoc analysis of a randomized controlled trial. Annals of intensive care, 11(1), 114. https://doi.org/10.1186/s13613-021-00892-8
Rodriguez, Maeva, et al. "Noninvasive ventilation vs. high-flow nasal cannula oxygen for preoxygenation before intubation in patients with obesity: a post hoc analysis of a randomized controlled trial." Annals of intensive care vol. 11,1 (2021): 114. doi: https://doi.org/10.1186/s13613-021-00892-8
Rodriguez M, Ragot S, Coudroy R, Quenot JP, Vignon P, Forel JM, Demoule A, Mira JP, Ricard JD, Nseir S, Colin G, Pons B, Danin PE, Devaquet J, Prat G, Merdji H, Petitpas F, Vivier E, Mekontso-Dessap A, Nay MA, Asfar P, Dellamonica J, Argaud L, Ehrmann S, Fartoukh M, Girault C, Robert R, Thille AW, Frat JP. Noninvasive ventilation vs. high-flow nasal cannula oxygen for preoxygenation before intubation in patients with obesity: a post hoc analysis of a randomized controlled trial. Ann Intensive Care. 2021 Jul 22;11(1):114. doi: 10.1186/s13613-021-00892-8. PMID: 34292408; PMCID: PMC8295638.
Copy Download .nbib Format: NLM
Differential Diagnosis between Marfan Syndrome and Loeys-Dietz Syndrome Type 4: A Novel Chromosomal Deletion Covering TGFB2.

Genes

Nistri S, De Cario R, Sticchi E, Spaziani G, Della Monica M, Giglio S, Favilli S, Giusti B, Stefano P, Pepe G.
PMID: 34680857
Genes (Basel). 2021 Sep 22;12(10). doi: 10.3390/genes12101462.

Marfan syndrome (MFS) and Loeys-Dietz syndrome type 4 (LDS4) are two hereditary connective tissue disorders. MFS displays ectopia lentis as a distinguishing, characterising feature, and thoracic aortic ectasia, aneurysm, dissection, and systemic features as manifestations overlapping with LDS4. LDS4...

Cite
Nistri S, De Cario R, Sticchi E, et al. Differential Diagnosis between Marfan Syndrome and Loeys-Dietz Syndrome Type 4: A Novel Chromosomal Deletion Covering TGFB2. Genes (Basel). 2021;12(10)doi: 10.3390/genes12101462.
Nistri, S., De Cario, R., Sticchi, E., Spaziani, G., Della Monica, M., Giglio, S., Favilli, S., Giusti, B., Stefano, P., & Pepe, G. (2021). Differential Diagnosis between Marfan Syndrome and Loeys-Dietz Syndrome Type 4: A Novel Chromosomal Deletion Covering TGFB2. Genes, 12(10), . https://doi.org/10.3390/genes12101462
Nistri, Stefano, et al. "Differential Diagnosis between Marfan Syndrome and Loeys-Dietz Syndrome Type 4: A Novel Chromosomal Deletion Covering TGFB2." Genes vol. 12,10 (2021). doi: https://doi.org/10.3390/genes12101462
Nistri S, De Cario R, Sticchi E, Spaziani G, Della Monica M, Giglio S, Favilli S, Giusti B, Stefano P, Pepe G. Differential Diagnosis between Marfan Syndrome and Loeys-Dietz Syndrome Type 4: A Novel Chromosomal Deletion Covering TGFB2. Genes (Basel). 2021 Sep 22;12(10). doi: 10.3390/genes12101462. PMID: 34680857; PMCID: PMC8536070.
Copy Download .nbib Format: NLM
[No title available]

American journal of respiratory and critical care medicine

Thille AW, Coudroy R, Nay MA, Gacouin A, Decavèle M, Sonneville R, Beloncle F, Girault C, Dangers L, Lautrette A, Levrat Q, Rouzé A, Vivier E, Lascarrou JB, Ricard JD, Mekontso-Dessap A, Barberet G, Lebert C, Ehrmann S, Massri A, Bourenne J, Pradel G, Bailly P, Terzi N, Dellamonica J, Lacave G, Robert R, Frat JP, Ragot S.
PMID: 34813391
Am J Respir Crit Care Med. 2021 Nov 23; doi: 10.1164/rccm.202106-1452OC. Epub 2021 Nov 23.

RATIONALE: Whereas non-invasive ventilation (NIV) may prevent reintubation in patients at high-risk of extubation failure in intensive care units (ICUs), this oxygenation strategy has not been specifically assessed in obese patients.OBJECTIVES: We hypothesized that NIV may decrease the risk...

Cite
Thille AW, Coudroy R, Nay MA, et al. . Am J Respir Crit Care Med. 2021;doi: 10.1164/rccm.202106-1452OC.
Thille, A. W., Coudroy, R., Nay, M. A., Gacouin, A., Decavèle, M., Sonneville, R., Beloncle, F., Girault, C., Dangers, L., Lautrette, A., Levrat, Q., Rouzé, A., Vivier, E., Lascarrou, J. B., Ricard, J. D., Mekontso-Dessap, A., Barberet, G., Lebert, C., Ehrmann, S., Massri, A., Bourenne, J., Pradel, G., Bailly, P., Terzi, N., Dellamonica, J., Lacave, G., Robert, R., Frat, J. P., Ragot, S. (2021). . American journal of respiratory and critical care medicine, . https://doi.org/10.1164/rccm.202106-1452OC
Thille, Arnaud W, et al. "." American journal of respiratory and critical care medicine vol. (2021). doi: https://doi.org/10.1164/rccm.202106-1452OC
Thille AW, Coudroy R, Nay MA, Gacouin A, Decavèle M, Sonneville R, Beloncle F, Girault C, Dangers L, Lautrette A, Levrat Q, Rouzé A, Vivier E, Lascarrou JB, Ricard JD, Mekontso-Dessap A, Barberet G, Lebert C, Ehrmann S, Massri A, Bourenne J, Pradel G, Bailly P, Terzi N, Dellamonica J, Lacave G, Robert R, Frat JP, Ragot S. . Am J Respir Crit Care Med. 2021 Nov 23; doi: 10.1164/rccm.202106-1452OC. Epub 2021 Nov 23. PMID: 34813391.
Copy Download .nbib Format: NLM
Proteinuria as a Biomarker for COVID-19 Severity.

Frontiers in physiology

Ouahmi H, Courjon J, Morand L, François J, Bruckert V, Lombardi R, Esnault V, Seitz-Polski B, Demonchy E, Dellamonica J, Boyer-Suavet S.
PMID: 33767630
Front Physiol. 2021 Mar 09;12:611772. doi: 10.3389/fphys.2021.611772. eCollection 2021.

BACKGROUND: Renal involvement in syndrome coronavirus 2 (SARS-CoV-2) infection has been retrospectively described, especially acute kidney injury (AKI). However, quantitative proteinuria assessment and its implication in coronavirus disease 2019 (COVID-19) remain unknown.METHODS: In this prospective, multicenter study in France,...

Cite
Ouahmi H, Courjon J, Morand L, et al. Proteinuria as a Biomarker for COVID-19 Severity. Front Physiol. 2021;12:611772doi: 10.3389/fphys.2021.611772.
Ouahmi, H., Courjon, J., Morand, L., François, J., Bruckert, V., Lombardi, R., Esnault, V., Seitz-Polski, B., Demonchy, E., Dellamonica, J., & Boyer-Suavet, S. (2021). Proteinuria as a Biomarker for COVID-19 Severity. Frontiers in physiology, 12611772. https://doi.org/10.3389/fphys.2021.611772
Ouahmi, Hajar, et al. "Proteinuria as a Biomarker for COVID-19 Severity." Frontiers in physiology vol. 12 (2021): 611772. doi: https://doi.org/10.3389/fphys.2021.611772
Ouahmi H, Courjon J, Morand L, François J, Bruckert V, Lombardi R, Esnault V, Seitz-Polski B, Demonchy E, Dellamonica J, Boyer-Suavet S. Proteinuria as a Biomarker for COVID-19 Severity. Front Physiol. 2021 Mar 09;12:611772. doi: 10.3389/fphys.2021.611772. eCollection 2021. PMID: 33767630; PMCID: PMC7985082.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 54 entries